-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EdCqzfYWQ/M7TOKf/FkBpaO8sT9/26jZYZj9uaC15uwcv6Qh3w5Vm/qTCuzyJQ5R Q/Ji29+FNOr85O6wUWEAAQ== 0000914121-09-001133.txt : 20090915 0000914121-09-001133.hdr.sgml : 20090915 20090915144001 ACCESSION NUMBER: 0000914121-09-001133 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090914 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20090915 DATE AS OF CHANGE: 20090915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 091069703 BUSINESS ADDRESS: STREET 1: 603 QUEENSBURY AVE CITY: QUEENSBURY STATE: NY ZIP: 12804 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 603 QUEENSBURY AVE CITY: QUEENSBURY STATE: NY ZIP: 12804 8-K 1 ad17321747-8k.txt CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2009 AngioDynamics, Inc. - -------------------------------------------------------------------------------- (Exact Name of Registrant as Specified in Charter) Delaware 000-50761 11-3146460 - -------------------------------------------------------------------------------- (State or Other Jurisdiction (Commission File (IRS Employer of Incorporation) Number) Identification No.) 603 Queensbury Avenue, Queensbury, New York 12804 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (518) 798-1215 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c)) Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. Effective September 14, 2009, David A. McDonald resigned as Sr. Vice President-Business Development of AngioDynamics. Mr. McDonald has agreed to provide consulting services to AngioDynamics, when and as requested, until October 31, 2009. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ANGIODYNAMICS, INC. (Registrant) Date: September 15, 2009 By: /s/ D. Joseph Gersuk -------------------- D. Joseph Gersuk Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----